Galecto Inc (GLTO)

$28.69 -0.22 (-0.76%)
Market Cap 45.83M
Revenue (ttm) 0.00
Net Income (ttm) -21.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 231,600
Avg Vol 195,912
Day's Range N/A - N/A
Shares Out 1.60M
Stochastic %K 31%
Beta 1.42
Analysts Strong Sell
Price Target $46.75

Company Profile

Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.

Industry: Biotechnology
Sector: Healthcare
Phone: 45 70 70 52 10
Website: galecto.com
Address:
Ole Maaloes Vej 3, Copenhagen N, Copenhagen, Denmark
justiceforb_85
justiceforb_85 Jun. 13 at 3:54 PM
$GLTO decent data presented by $INCY for INCA033989 in ET/MF. However, DMR-001 has a possible edge due to activity in non-type 1 CALR mutations and ease of administration (SC versus IV).
0 · Reply
HadesHODL
HadesHODL Jun. 12 at 3:07 PM
$GLTO
0 · Reply
justiceforb_85
justiceforb_85 May. 22 at 6:33 PM
$GLTO started a position. DMR-001 will build on the success of INCA033989 by $INCY and target both type 1 and non-type 1 CALR mutations with a more convenient administration (SC).
0 · Reply
MilsLearning
MilsLearning May. 22 at 9:36 AM
$GLTO
0 · Reply
justiceforb_85
justiceforb_85 May. 20 at 7:31 AM
$GLTO when can stocktwits change this to DMRA 😆.
0 · Reply
NotHopeJustFacts
NotHopeJustFacts Apr. 27 at 1:54 PM
$GLTO so this changed to $DMRA but stocktwits don't know about it yet ?
0 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 7 at 6:19 PM
$NEUP Both the $GLTO and $BRNS CEO's sent me similiar responses and then the deal was announced with 10 days of each of them...so assuming timing is always iffy. But this is a good, solid response. Thanks for sharing.
0 · Reply
BSMARKET
BSMARKET Mar. 18 at 1:57 PM
$GLTO @Stocktwits new thicker $DMRA
0 · Reply
taki
taki Mar. 16 at 9:44 AM
$GLTO Imagine a stock which is about to skyrocket but nobody is participating.
0 · Reply
EyeYamStewPeed
EyeYamStewPeed Mar. 10 at 10:56 PM
$GLTO ww
0 · Reply
Latest News on GLTO
No data available.
justiceforb_85
justiceforb_85 Jun. 13 at 3:54 PM
$GLTO decent data presented by $INCY for INCA033989 in ET/MF. However, DMR-001 has a possible edge due to activity in non-type 1 CALR mutations and ease of administration (SC versus IV).
0 · Reply
HadesHODL
HadesHODL Jun. 12 at 3:07 PM
$GLTO
0 · Reply
justiceforb_85
justiceforb_85 May. 22 at 6:33 PM
$GLTO started a position. DMR-001 will build on the success of INCA033989 by $INCY and target both type 1 and non-type 1 CALR mutations with a more convenient administration (SC).
0 · Reply
MilsLearning
MilsLearning May. 22 at 9:36 AM
$GLTO
0 · Reply
justiceforb_85
justiceforb_85 May. 20 at 7:31 AM
$GLTO when can stocktwits change this to DMRA 😆.
0 · Reply
NotHopeJustFacts
NotHopeJustFacts Apr. 27 at 1:54 PM
$GLTO so this changed to $DMRA but stocktwits don't know about it yet ?
0 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 7 at 6:19 PM
$NEUP Both the $GLTO and $BRNS CEO's sent me similiar responses and then the deal was announced with 10 days of each of them...so assuming timing is always iffy. But this is a good, solid response. Thanks for sharing.
0 · Reply
BSMARKET
BSMARKET Mar. 18 at 1:57 PM
$GLTO @Stocktwits new thicker $DMRA
0 · Reply
taki
taki Mar. 16 at 9:44 AM
$GLTO Imagine a stock which is about to skyrocket but nobody is participating.
0 · Reply
EyeYamStewPeed
EyeYamStewPeed Mar. 10 at 10:56 PM
$GLTO ww
0 · Reply
drwaz
drwaz Mar. 10 at 9:18 AM
$GLTO 👀
0 · Reply
Jozie12clicks
Jozie12clicks Mar. 3 at 8:40 PM
$GLTO lol this guy! Said it would never ever go past 25 ran to 38 unblocked me just to say this and then blocked me again. This novice made just over $5000 on its run to 38.🤪
1 · Reply
StockConsultant
StockConsultant Feb. 25 at 4:48 AM
$GLTO Galecto stock, watch for a bull flag breakout, target 42+ area
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 23 at 2:57 PM
$GLTO Current Stock Price: $30.25
0 · Reply
MillionTrader_xy
MillionTrader_xy Feb. 18 at 1:13 PM
$SNSE $GLTO Move incoming https://www.businesswire.com/news/home/20260217234993/en/Sensei-Biotherapeutics-Announces-Acquisition-of-Faeth-Therapeutics-and-%24200-Million-Concurrent-Private-Placement
0 · Reply
notreload_ai
notreload_ai Feb. 17 at 3:00 PM
$GLTO , $KRRO ... William Blair boosts Korro Bio to Outperform with favorable risk/reward, while UBS starts Galecto at Buy with a $45 target on its promising blood disorder therapy. https://notreload.xyz/analyst-upgrades-boost-two-biotech-stocks-korro-bio-galecto/
0 · Reply